fanasil, pyrimethamine drug combination has been researched along with Birth Weight in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (30.30) | 29.6817 |
| 2010's | 14 (42.42) | 24.3611 |
| 2020's | 9 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Bartelt, LA; Carroll, I; Chinkhumba, J; Gutman, JR; Itoh, M; Juliano, JJ; Kayange, M; Mathanga, DP; McQuade, ETR; Meshnick, SR; Mzembe, E; Operario, DJ; Puerto-Meredith, SM; Waltmann, A | 1 |
| Afagbedzi, S; Guure, C | 1 |
| Achidi, EA; Amambua-Ngwa, A; Anchang-Kimbi, JK; Apinjoh, TO; Chi, HF; Dionne-Odom, J; Kwi, PN; Mayaba, JM; Moyeh, MN; Ntui, VN; Tangi, LN; Tita, ATN; Titanji, VPK; Toussi, CT | 1 |
| Derra, K; Donnen, P; Dramaix, M; Kaboré, B; Lingani, M; Robert, A; Rouamba, T; Samadoulougou, S; Sanou, M; Somé, G; Sorgho, H; Tahita, MC; Tinto, H; Valéa, I; Zango, SH | 1 |
| Abram, A; Alruwaili, M; Eckert, E; Gutman, JR; Mbituyumuremyi, A; Munguti, K; Murindahabi, M; Piercefield, E; Sethi, R; Sullivan, DJ; Umulisa, N; Uwimana, A | 1 |
| Agboghoroma, CO; Iregbu, KC; Umemmuo, MU | 1 |
| Anang, AK; Asare, GQ; Coleman, N; Cot, M; Cottrell, G; Deloron, P; Escriou, G; Fobil, J; Houze, P; Kusi, KA; Laar, A; Ndam, NT; Ofori, MF; Quakyi, I; Tornyigah, B | 1 |
| Ayivi-Vinz, G; Azandjèmé, C; Biaou, COA; Glèlè-Ahanhanzo, Y; Kpozehouen, A; Ouro-Koura, AR | 1 |
| Freedman, B; Kalilani-Phiri, L; Khairallah, C; Levitt, B; Madanitsa, M; Meshnick, SR; Mwapasa, V; Taylor, SM; Ter Kuile, FO; Thwai, KL | 1 |
| Davis, TME; Moore, B; Salman, S | 1 |
| Chico, RM; Desai, M; Dorsey, G; Glymour, MM; Gosling, R; Gutman, J; Kajubi, R; Kakuru, A; Kamya, MR; Kuile, FOT; L'Ianziva, A; Rerolle, F; Roh, ME; Shiboski, S | 1 |
| Ashorn, P; Ashorn, U; Cheung, YB; Hallamaa, L; Kulmala, T; Luntamo, M; Mangani, C | 1 |
| Ashorn, P; Cheung, YB; Kulmala, T; Luntamo, M; Maleta, K | 1 |
| Chilongola, J; Genton, B; Mosha, D; Mwingira, F; Ndeserua, R | 1 |
| Alifrangis, M; Birungi, J; Magnussen, P; Malamba, S; Mbonye, AK; Shokoples, S; Yanow, SK | 1 |
| Abubakar, I; Akor, F; Awine, T; Bationo, R; Bojang, K; Cairns, M; Chandramohan, D; Coulibaly, SO; Dabira, E; Djimdé, M; Doumbo, O; Greenwood, B; Guirou, E; Hodgson, A; Kayentao, K; Magnussen, P; Meshnick, S; Milligan, P; Mohammed, K; Njie, F; Oduro, A; Ordi, J; Quaye, S; Soulama, A; Tagbor, H; Taylor, S; ter Kuile, F; Williams, J; Woukeu, A | 1 |
| Boeuf, P; Karl, S; Mueller, I; Ome-Kaius, M; Rogerson, SJ; Unger, HW; Wangnapi, RA | 1 |
| Ambounda, N; Bouyou-Akotet, MK; Kendjo, E; Kombila, M; Mawili-Mboumba, DP; Moutandou Chiesa, S; Tshibola Mbuyi, ML; Tsoumbou-Bakana, G; Zong, J | 1 |
| Cairns, M; Floyd, J; Ter Kuile, F; Walker, PG | 1 |
| Coulibaly, SO; D'Alessandro, U; Gies, S; Ouattara, FT | 1 |
| Brabin, BJ; D'Alessandro, U; Gies, S; Kalanda, G; Kazembe, PN; Msyamboza, KP; Savage, EJ | 1 |
| Atua, B; Emch, M; Hand, CC; Meshnick, SR; Messina, JP; Muwonga, J; Mwandagalirwa, K; Taylor, SM; Ter Kuile, FO; Tshefu, AK; van Eijk, AM | 1 |
| D'Alessandro, U; Dramaix, MW; Likwela, JL; Lokwa, BL; Meuris, S | 1 |
| Borgella, S; Briand, V; Cot, M; Deloron, P; Fievet, N; Huynh, BT; Massougbodji, A | 1 |
| Ayisi, JG; Kager, PA; Misore, AO; Nahlen, BL; Odondi, JO; Otieno, JA; Rosen, DH; Steketee, RW; ter Kuile, FO; van Eijk, AM | 1 |
| Bergström, S; Challis, K; Cotiro, M; Dgedge, M; Nordahl, G; Osman, NB | 1 |
| Coulibaly, D; Doumbo, O; Doumtabe, D; Kayentao, K; Keita, AS; Kodio, M; Maiga, B; Maiga, H; Mungai, M; Newman, RD; Ongoiba, A; Parise, ME | 1 |
| Madaki, JK; Sagay, AS; Thacher, TD; Tukur, IU | 1 |
| Fadero, FF; Falade, CO; Hamer, DH; Mokuolu, OA; Salako, LA; Yusuf, BO | 1 |
| Acquah, PA; Bedu-Addo, G; Bienzle, U; Eggelte, TA; Holmberg, V; Hommerich, L; Mockenhaupt, FP; von Oertzen, C | 1 |
| Chalwe, V; Champo, D; Chilengi, R; Gill, CJ; Hamer, DH; Macleod, WB; Mukwamataba, D; Mwanakasale, V; Mwananyanda, L; Thea, DM | 1 |
| Chalwe, V; Champo, D; Chilengi, R; Gill, CJ; Hamer, DH; Macleod, WB; Mubikayi, L; Mukwamataba, D; Mulele, CK; Mulenga, M; Mwanakasale, V; Mwananyanda, L; Thea, DM | 1 |
15 trial(s) available for fanasil, pyrimethamine drug combination and Birth Weight
| Article | Year |
|---|---|
The positive effect of malaria IPTp-SP on birthweight is mediated by gestational weight gain but modifiable by maternal carriage of enteric pathogens.
Topics: Antimalarials; Birth Weight; Cryptosporidiosis; Cryptosporidium; Drug Combinations; Escherichia coli; Female; Gestational Weight Gain; Humans; Infant; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2022 |
Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial.
Topics: Abortion, Spontaneous; Antimalarials; Azithromycin; Birth Weight; Burkina Faso; Drug Combinations; Female; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Malaria; Pregnancy; Premature Birth; Pyrimethamine; Stillbirth; Sulfadoxine | 2023 |
Interactions Between Antenatal Sulfadoxine-Pyrimethamine, Drug-Resistant Plasmodium falciparum Parasites, and Delivery Outcomes in Malawi.
Topics: Adolescent; Adult; Animals; Birth Weight; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant, Newborn; Linear Models; Malaria, Falciparum; Malawi; Mutation, Missense; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2020 |
Overall, anti-malarial, and non-malarial effect of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine on birthweight: a mediation analysis.
Topics: Adult; Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Infant, Newborn; Kenya; Malaria; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Uganda; Young Adult | 2020 |
The impact of maternal antenatal treatment with two doses of azithromycin and monthly sulphadoxine-pyrimethamine on child weight, mid-upper arm circumference and head circumference: A randomized controlled trial.
Topics: Adult; Anti-Bacterial Agents; Antimalarials; Arm; Azithromycin; Birth Weight; Child; Child, Preschool; Drug Combinations; Female; Follow-Up Studies; Head; Humans; Incidence; Infant; Infant, Newborn; Malaria; Malawi; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Parasitic; Pyrimethamine; Respiratory Tract Infections; Sulfadoxine | 2019 |
The effect of antenatal monthly sulphadoxine-pyrimethamine, alone or with azithromycin, on foetal and neonatal growth faltering in Malawi: a randomised controlled trial.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antimalarials; Azithromycin; Birth Weight; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Fetal Development; Humans; Infant, Newborn; Malaria, Falciparum; Malawi; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Reproductive Tract Infections; Sulfadoxine; Young Adult | 2013 |
A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy.
Topics: Adolescent; Adult; Africa; Antimalarials; Birth Weight; Burkina Faso; Drug Combinations; Female; Gambia; Ghana; Hemoglobins; Humans; Malaria; Mali; Mass Screening; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2015 |
Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
Topics: Adult; Anemia; Animals; Antimalarials; Birth Weight; Burkina Faso; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Logistic Models; Malaria, Falciparum; Parasitemia; Placenta; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Young Adult | 2009 |
Consequences of gestational malaria on birth weight: finding the best timeframe for intermittent preventive treatment administration.
Topics: Adolescent; Adult; Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Infant, Newborn; Malaria; Mefloquine; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2012 |
Impact of a double dose of sulphadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique.
Topics: Adolescent; Adult; Antimalarials; Birth Weight; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Humans; Malaria; Parasitemia; Patient Selection; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prenatal Care; Pyrimethamine; Sulfadoxine | 2004 |
Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali.
Topics: Abortion, Spontaneous; Adolescent; Adult; Anemia; Birth Weight; Chemoprevention; Chloroquine; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Mali; Multivariate Analysis; Parasitemia; Placenta Diseases; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Sulfadoxine | 2005 |
A comparison of sulfadoxine-pyrimethamine with chloroquine and pyrimethamine for prevention of malaria in pregnant Nigerian women.
Topics: Adult; Animals; Antimalarials; Birth Weight; Chloroquine; Drug Combinations; Female; Hematocrit; Humans; Infant, Newborn; Malaria, Falciparum; Nigeria; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2007 |
Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria.
Topics: Adolescent; Adult; Antimalarials; Birth Weight; Dizziness; Drug Combinations; Female; Humans; Malaria; Male; Nigeria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2007 |
Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antimalarials; Birth Weight; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Fetal Blood; Hemoglobins; Humans; Incidence; Malaria; Odds Ratio; Parasitemia; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Outcome; Zambia | 2007 |
Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia; Antimalarials; Birth Weight; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Fetal Blood; Hemoglobins; HIV Seropositivity; Humans; Incidence; Malaria, Falciparum; Odds Ratio; Parasitemia; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pyrimethamine; Risk Factors; Sulfadoxine; Treatment Outcome; Zambia | 2007 |
18 other study(ies) available for fanasil, pyrimethamine drug combination and Birth Weight
| Article | Year |
|---|---|
Predicting the effect of sulfadoxine-pyrimethamine uptake by pregnant women on birth weight using a generalized ordered partial proportional odds model.
Topics: Adult; Antimalarials; Birth Weight; Demography; Drug Combinations; Female; Fetal Macrosomia; Ghana; Humans; Infant, Low Birth Weight; Malaria; Models, Statistical; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine | 2022 |
Intermittent preventive treatment with Sulphadoxine-Pyrimethamine (IPTp-SP) is associated with protection against sub-microscopic P. falciparum infection in pregnant women during the low transmission dry season in southwestern Cameroon: A Semi - longitudi
Topics: Antimalarials; Birth Weight; Cameroon; Drug Combinations; Female; Humans; Infant, Newborn; Insecticides; Longitudinal Studies; Malaria; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Pregnancy; Pregnancy Outcome; Pregnant Women; Pyrimethamine; Seasons; Sulfadoxine | 2022 |
Peripheral and Placental Prevalence of Sulfadoxine-Pyrimethamine Resistance Markers in Plasmodium falciparum among Pregnant Women in Southern Province, Rwanda.
Topics: Antimalarials; Birth Weight; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Malaria, Falciparum; Placenta; Plasmodium falciparum; Polymorphism, Single Nucleotide; Pregnancy; Pregnant Women; Prevalence; Pyrimethamine; Rwanda; Sulfadoxine | 2023 |
The efficacy of intermittent preventive therapy in the eradication of peripheral and placental parasitemia in a malaria-endemic environment, as seen in a tertiary hospital in Abuja, Nigeria.
Topics: Adolescent; Adult; Antimalarials; Birth Weight; Cross-Sectional Studies; Drug Combinations; Female; Humans; Infant, Newborn; Malaria; Nigeria; Parasitemia; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Tertiary Care Centers | 2020 |
High uptake of Intermittent Preventive Treatment of malaria in pregnancy is associated with improved birth weight among pregnant women in Ghana.
Topics: Adolescent; Adult; Birth Weight; Cohort Studies; Drug Combinations; Female; Ghana; Humans; Linear Models; Malaria; Middle Aged; Multivariate Analysis; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Prevalence; Pyrimethamine; Sulfadoxine; Young Adult | 2019 |
[Sulfadoxine-pyrimethamine-based intermittent preventive treatment in pregnant women and its effect on birth weight: application of 3-dosing regimen in the urban area of South Benin in 2017].
Topics: Adult; Antimalarials; Benin; Birth Weight; Cross-Sectional Studies; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Male; Medication Adherence; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Surveys and Questionnaires; Young Adult | 2019 |
Defining the combined benefit of intermittent preventive malaria treatment in pregnancy.
Topics: Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Malaria; Pregnancy; Pyrimethamine; Sulfadoxine | 2020 |
Bigger babies for women given extra prophylaxis against malaria.
Topics: Africa South of the Sahara; Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Infant, Newborn; Malaria; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; World Health Organization | 2013 |
Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
Topics: Adult; Anemia; Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Malaria, Falciparum; Numbers Needed To Treat; Parasitemia; Placenta; Placenta Diseases; Pregnancy; Pregnancy Complications; Pregnancy Complications, Parasitic; Prevalence; Prospective Studies; Pyrimethamine; Risk; Sulfadoxine; Tanzania; Treatment Outcome; Young Adult | 2014 |
Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda.
Topics: Antimalarials; Bacterial Proteins; Birth Weight; Drug Combinations; Female; Humans; Malaria, Falciparum; Plasmodium falciparum; Pregnancy; Pregnancy Outcome; Pyrimethamine; Sulfadoxine; Uganda | 2015 |
Azithromycin-containing intermittent preventive treatment in pregnancy affects gestational weight gain, an important predictor of birthweight in Papua New Guinea - an exploratory analysis.
Topics: Adolescent; Antimalarials; Azithromycin; Birth Weight; Body Mass Index; Drug Combinations; Female; Follow-Up Studies; Humans; Infant, Low Birth Weight; Linear Models; Malnutrition; Maternal Exposure; Multivariate Analysis; Nutritional Status; Papua New Guinea; Pregnancy; Pyrimethamine; Risk Factors; Socioeconomic Factors; Sulfadoxine; Weight Gain | 2016 |
Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
Topics: Adult; Anemia; Antimalarials; Birth Weight; Cities; Cross-Sectional Studies; Drug Combinations; Female; Gabon; Gravidity; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Malaria, Falciparum; Parasitemia; Placenta; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prevalence; Pyrimethamine; Sulfadoxine; Urban Population; Young Adult | 2016 |
Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
Topics: Africa South of the Sahara; Antimalarials; Birth Weight; Child; Child, Preschool; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Malaria; Models, Theoretical; Pregnancy; Pyrimethamine; Sulfadoxine | 2017 |
Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi.
Topics: Adolescent; Adult; Anemia; Antimalarials; Birth Weight; Community Health Services; Drug Combinations; Female; Humans; Malaria; Malawi; Parasitemia; Patient Acceptance of Health Care; Pregnancy; Prenatal Care; Prevalence; Program Evaluation; Pyrimethamine; Sulfadoxine | 2009 |
Quantification of the burden and consequences of pregnancy-associated malaria in the Democratic Republic of the Congo.
Topics: Anemia; Antimalarials; Birth Weight; Cross-Sectional Studies; Democratic Republic of the Congo; Drug Combinations; Female; Humans; Infant, Newborn; Insecticide-Treated Bednets; Malaria, Falciparum; Parasitemia; Plasmodium falciparum; Plasmodium malariae; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Prevalence; Pyrimethamine; Real-Time Polymerase Chain Reaction; Sulfadoxine | 2011 |
Sulfadoxine-pyrimethamine resistance and intermittent preventive treatment during pregnancy: a retrospective analysis of birth weight data in the Democratic Republic of Congo (DRC).
Topics: Adolescent; Adult; Antimalarials; Birth Weight; Congo; Drug Combinations; Drug Resistance; Female; Fetal Development; Gravidity; Humans; Infant, Low Birth Weight; Infant, Newborn; Logistic Models; Malaria; Pregnancy; Pregnancy Outcome; Pyrimethamine; Retrospective Studies; Risk Factors; Sulfadoxine; Young Adult | 2012 |
Effectiveness of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antimalarials; Birth Weight; Cohort Studies; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Kenya; Malaria; Placenta Diseases; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Pyrimethamine; Sulfadoxine; Time Factors; Treatment Outcome | 2004 |
Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.
Topics: Adolescent; Adult; Anemia; Animals; Antimalarials; Birth Weight; Chemoprevention; Drug Administration Schedule; Drug Combinations; Female; Ghana; Humans; Infant, Newborn; Malaria, Falciparum; Middle Aged; Placenta; Placenta Diseases; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Rural Population; Sulfadoxine; Treatment Outcome | 2007 |